scispace - formally typeset
V

Vito R. Petretta

Researcher at University of Naples Federico II

Publications -  12
Citations -  887

Vito R. Petretta is an academic researcher from University of Naples Federico II. The author has contributed to research in topics: Cardiomyopathy & Muscular dystrophy. The author has an hindex of 11, co-authored 12 publications receiving 849 citations.

Papers
More filters
Journal ArticleDOI

Development of Cardiomyopathy in Female Carriers of Duchenne and Becker Muscular Dystrophies

TL;DR: Genetic anomalies can be considered the primary cause of myocardial damage in carriers of dystrophinopathic myopathies and shows the same behavior already described in DMD and BMD patients and progresses from preclinical to dilated cardiomyopathy, passing through stages ofMyocardial hypertrophy or dysrhythmias.
Journal ArticleDOI

Evaluation of cardiac and respiratory involvement in sarcoglycanopathies.

TL;DR: Signs of hypoxic myocardial damage occurred in beta-, gamma- and delta-sarcoglycanopathies, while initial signs of a dilated cardiomyopathy in gamma-and delta-Sarcogly canopathies were found.
Journal ArticleDOI

Evaluation of the cardiomyopathy in becker muscular dystrophy

TL;DR: It is confirmed that cardiac dysfunction is a primary feature of Becker muscular dystrophy and that a real, dilated cardiomyopathy is the most frequent type of myocardial involvement after the age of 20.
Journal ArticleDOI

Prospective study of X-linked progressive muscular dystrophy in Campania

TL;DR: Within the Campania region of southern Italy a prospective study on X‐linked progressive muscular dystrophy was conducted over a period of 12 years from 1969 to 1980, inclusive, which includes the effects of age on physical performance, serum creatine kinase activity and serum myoglobin levels, the types of cardiac damage, and the causes of death.
Journal ArticleDOI

Mutation of dystrophin gene and cardiomyopathy

TL;DR: The correlations between the type of gene mutation and the cardiac clinical picture were examined in 284 patients with dystrophinopathy and the age of death was 18 years in DMD patients with deletions including 48-49 whereas the age was about 22 in the cases with other deletions.